0001104659-16-139254.txt : 20160812 0001104659-16-139254.hdr.sgml : 20160812 20160812124723 ACCESSION NUMBER: 0001104659-16-139254 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160810 FILED AS OF DATE: 20160812 DATE AS OF CHANGE: 20160812 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gemphire Therapeutics Inc. CENTRAL INDEX KEY: 0001638287 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472389984 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 43334 7 MILE ROAD STREET 2: SUITE 1000 CITY: NORTHVILLE STATE: MI ZIP: 48167 BUSINESS PHONE: 248-980-6538 MAIL ADDRESS: STREET 1: 43334 7 MILE ROAD STREET 2: SUITE 1000 CITY: NORTHVILLE STATE: MI ZIP: 48167 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bisgaier Charles PhD CENTRAL INDEX KEY: 0001381030 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37809 FILM NUMBER: 161827311 MAIL ADDRESS: STREET 1: 3985 RESEARCH PARK DRIVE CITY: ANN ARBOR STATE: MI ZIP: 48108 4 1 a4.xml 4 X0306 4 2016-08-10 0 0001638287 Gemphire Therapeutics Inc. GEMP 0001381030 Bisgaier Charles PhD 43334 SEVEN MILE ROAD SUITE 1000 NORTHVILLE MI 48167 1 1 1 0 Chair & Chief Scientific Off. Common Stock 2016-08-10 4 C 0 59561 A 59561 I Held by The Charles L. Bisgaier Trust Common Stock 2016-08-10 4 J 0 6515 6.7059 A 66076 I Held by The Charles L. Bisgaier Trust Common Stock 2016-08-10 4 C 0 16144 6.7059 A 82220 I Held by The Charles L. Bisgaier Trust Common Stock 2016-08-10 4 C 0 19228 6.7059 A 19228 I Held by Bisgaier Family, LLC Common Stock 2016-08-10 4 P 0 51750 10.00 A 1244440 D Series A Convertible Preferred Stock 2016-08-10 4 C 0 59561 0 D Common Stock 59561 0 I Held by The Charles L. Bisgaier Trust 8% Convertible Subordinated Promissory Notes 6.7059 2016-08-10 4 C 0 100000 0 D Common Stock 16144 0 I Held by The Charles L. Bisgaier Trust 8% Convertible Subordinated Promissory Notes 6.7059 2016-08-10 4 C 0 125000 0 D Common Stock 19228 0 I Held by Bisgaier Family, LLC The Series A Convertible Preferred Stock converted into shares of common stock, par value $0.001 per share (the "Common Stock"), of Gemphire Therapeutics Inc. (the "Company") on a one-for-one basis immediately prior to the closing of the Company's initial public offering and had no expiration date. These shares are indirectly owned by the reporting person as trustee of The Charles L. Bisgaier Trust. Represents shares of Common Stock issued for payment of accrued dividends on the Series A Convertible Preferred Stock. The notes were issued in the original principal amount of $100,000. The outstanding principal and $8,263 of accrued interest on the notes automatically converted into shares of Common Stock immediately prior to the closing of the Company's initial public offering. The notes were issued in the original principal amount of $125,000. The outstanding principal and $3,945 of accrued interest on the notes automatically converted into shares of Common Stock immediately prior to the closing of the Company's initial public offering. /s/ Stephanie Swan, by Power of Attorney 2016-08-12